[1] 胡冬梅,车小燕. 登革热中和抗体的研究进展[J]. 中华预防医学杂志,2010,44(10):938-940. DOI:10.3760/cma.j.issn.0253-9624.2010.10.020. [2] 袁伟壮,杨逸成,刘旭玲,等. 抗体依赖增强效应发生机制研究进展[J]. 中国人兽共患病学报,2017,33(7):650-657. DOI:10.3969/j.issn.1002-2694.2017.07.015. [3] Sun JM,Lin JF,Yan JY,et al. Dengue virus serotype 3 subtype Ⅲ,Zhejiang province,China[J]. Emerg Infect Dis,2011,17(2):321-323. DOI:10.3201/eid1702.100396. [4] Luo SY,Cui WH,Li C,et al. Seroprevalence of dengue IgG antibodies in symptomatic and asymptomatic individuals three years after an outbreak in Zhejiang province,China[J]. BMC Infect Dis,2018,18:92. DOI:10.1186/s12879-018-3000-5. [5] Sun JM,Luo SY,Lin JF,et al. Inapparent infection during an outbreak of dengue fever in Southeastern China[J]. Viral Immunol,2012,25(6):456-460. DOI:10.1089/vim.2012.0039. [6] 杜建伟,潘先海. 中国登革热流行概况与流行特征[J].中华流行病学杂志,2010,31(12):1429-1433. DOI:10.3760/cma.j.issn.0254-6450.2010.12.025. [7] 郎欣月,何晓恩,刘旭玲,等. 登革病毒病原学研究进展[J]. 中国病原生物学杂志,2018,13(11):1292-1295,1299. DOI:10.13350/j.cjpb.181126. [8] 张萌,何剑峰. 登革热流行趋势研究进展[J]. 新发传染病电子杂志,2018,3(2):72-74. DOI:10.3877/j.issn.2096-2738.2018. 02.004. [9] 凌锋,范伟忠,林君芬,等. 浙江省义乌市一起登革热暴发疫情流行病学调查[J]. 疾病监测,2010,25(9):757-759. DOI:10.3784/j.issn.1003-9961.2010.09.028. [10] Poland JD,Calisher CH,Monath TP,et al. Persistence of neutralizing antibody 30-35 years after immunization with 17D yellow fever vaccine[J].Bull World Health Organ,1981,59(6):895-900. [11] Imrie A,Meeks J,Gurary A,et al. Antibody to dengue 1 detected more than 60 years after infection[J]. Viral Immunol,2007,20(4):672-675. DOI:10.1089/vim.2007.0050. [12] Ngwe Tun MM,Muta Y,Inoue S,et al. Persistence of neutralizing antibody against Dengue virus 2 after 70 years from infection in Nagasaki[J]. Bio Res Open Access,2016,5(1):188-191. DOI:10.1089/biores.2016.0016.sn.0253-9624.2010.10. 020. |